EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil.
Icaro Alves PintoRodrigo de Oliveira CavagnaAline Larissa Virginio da SilvaJosiane Mourão DiasIara Vidigal SantanaLaísa Caroline SouzaFlávio Augusto Ferreira da SilvaMaria Fernanda Biazotto FernandesGustavo Dix Junqueira PintoIzabella Santos NegreirosMaria Fernanda Santiago GonçalvesFlávia Escremim de PaulaGustavo Nóriz BerardinelliGiovanna Maria Stanfoca CasagrandeMarcela Oliveira da SilvaEduardo Caetano Albino da SilvaMarco Antonio de OliveiraAlexandre Arthur JacintoVinicius Duval da SilvaRui Manuel Vieira ReisPedro De MarchiLetícia Ferro LealPublished in: The oncologist (2022)
The frequencies of EGFR mutations and PD-L1 positivity were described for early-stage non-squamous patients with NSCLC. These results will be essential for guiding treatment strategies with the recent approvals of osimertinib and immunotherapy in the adjuvant setting.